Keith Rubin
Internal Medicine · Fort Lauderdale, FLNPI 1043674062
Payments from drug & device makers
$2,017,582in general payments, 2019–2025
Across 13 payments — averaging $155,199 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kaleo, Inc.$2M
- Amarin Pharma, Inc.$97
- Lilly USA, LLC$31
- Eisai Inc.$20
- Alnylam Pharmaceuticals Inc.$19
What the payments were for
- Food & beverage$1680%
- Other$2,017,414100%
General payments by program year
20
21
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kaleo, Inc. | 3 | $2,017,414 |
| Amarin Pharma, Inc. | 6 | $97 |
| Lilly USA, LLC | 2 | $31 |
| Eisai Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
How this compares
$2,017,582 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Fort Lauderdale
- Bernard GarciaFort Lauderdale$5.6M
- Thomas WadeFort Lauderdale$4.7M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.